HSP90AA1 and pancreatic neoplasm: To assess whether our observations regarding the impact of the HSP90 charged linker, derived from cell models, extend to human patients and are not artifacts specific to cultured cells, we obtained surgical specimens from breast and pancreatic cancer surgeries (n = 18 tissues from 9 patients, Fig. 10a–d).